• Flexible Phage Capture for Cancer Cell Subtyping

  2026-09-10

  The reference study introduces flexible M13 bacteriophage nanofibers as adaptive capture elements for enriching rare circulating tumor cells from blood while limiting white blood cell adsorption. By combining mechanically responsive phages with magnetic separation and immunostaining, the authors improved discrimination between breast cancer patients and healthy donors and enabled cancer subtype classification.

• Nocodazole in Cytoskeletal Entry Assays

  2026-09-10

  Nocodazole is most informative when used as a reversible mechanistic control rather than a stand-alone entry inhibitor. This article connects β-tubulin pharmacology with Spiroplasma eriocheiris infection biology, explains how to separate entry from post-entry effects, and provides practical guidance for translational assay design.

• Potassium Iodide: Designing Better Thyroid Assays

  2026-09-09

  Potassium Iodide (KI) is more than a thyroid-related reagent: it is a controllable iodide variable for mechanistic assay design. This article connects thyroid protection research with lessons from responsive immunotherapy while clearly separating validated evidence from experimental extrapolation.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit Guide

  2026-09-09

  Build bright, tunable RNA probes for in situ hybridization, Northern blot hybridization, and RNA–protein condensation assays. This workflow explains how to balance Cy5-UTP incorporation against transcription yield while using the SARS-CoV-2 nucleocapsid study to design more informative fluorescence experiments.

• Annexin V-Cy5/DAPI Apoptosis Kit: A Decision Framework

  2026-09-08

  Use the Annexin V-Cy5/DAPI Apoptosis Kit to convert phosphatidylserine exposure and membrane integrity into interpretable cell-death states. This article connects the assay to P2RX1-driven mitochondrial apoptosis in Ph+ ALL while emphasizing experimental design, controls, and mechanistic limits.

• IGF2BP1–THBS1–TLR4 Axis in Pulmonary Fibrosis

  2026-09-08

  A 2025 study identifies an m6A-dependent IGF2BP1–THBS1–TLR4 pathway that links macrophage glycolytic reprogramming with fibrotic activation in bleomycin-induced pulmonary fibrosis. Its knockdown, rescue, and metabolic experiments provide a mechanistic framework for studying how RNA modification controls macrophage–fibroblast interactions and lung remodeling.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody Guide

  2026-09-07

  Build sensitive fluorescence workflows for tracking ASB3–MAVS antiviral signaling with a Cy5 conjugated secondary antibody. This practical guide covers immunofluorescence, western blotting, immunohistochemistry, flow cytometry, quantitative controls, and troubleshooting without mistaking fluorescence intensity for proof of mechanism.

• Western Secondary Antibody Dilution Buffer Guide

  2026-09-07

  Improve macrophage and plaque-protein Western blots with a stabilized secondary antibody workflow designed for cleaner backgrounds and more consistent reuse. This guide translates NHE1–Olfr2 atherosclerosis findings into practical assay choices, controls, and troubleshooting steps.

• HyperFusion high-fidelity DNA polymerase Workflow

  2026-09-05

  Build more reliable PCR workflows for GC-rich, long, or sequence-sensitive neurogenetics assays with a proofreading DNA polymerase engineered for speed, accuracy, and inhibitor tolerance. This guide connects precise amplicon generation with the C. elegans pheromone–neurodegeneration model while separating established findings from practical assay recommendations.

• Five-Element Nanoparticles for Stable Lung mRNA Delivery

  2026-09-04

  The reference study develops five-element nanoparticles (FNPs) that combine helper-polymer PBAEs with DOTAP to improve lung-specific mRNA delivery and formulation stability. Its structure–activity analysis and lyophilization results suggest a practical route toward mRNA formulations that tolerate refrigerated storage, although the evidence remains preclinical and formulation-specific.

• ARCA Cy5 EGFP mRNA (5-moUTP) Workflow Guide

  2026-09-04

  Track mRNA uptake and protein expression in the same mammalian-cell experiment with a covalently Cy5-labeled, EGFP-encoding reporter. This practical guide combines fluorescence microscopy, flow cytometry, transfection optimization, and delivery-system troubleshooting around one dual-readout reagent.

• Targeting Tumor-Associated Bacteria to Limit Metastasis

  2026-09-03

  Kang et al. developed a polyvalent nanovaccine that combines soluble and insoluble bacterial antigens to selectively eliminate tumor-associated bacteria linked to breast cancer metastasis. The study shows how immune-based control of the intratumoral microbiome may complement conventional cancer therapy while highlighting important questions about bacterial specificity, model translation, and immune mechanisms.

• Aprotinin and the Protease-to-Transcriptome Bridge

  2026-09-03

  A mechanistic and strategic framework for using Aprotinin as a serine protease perturbation tool, while pairing biochemical validation with GRO-seq to connect protease activity, inflammation, and nascent transcription.

• N1-Methylpseudouridine: Practical mRNA Workflows

  2026-09-02

  N1-Methylpseudouridine helps researchers build mRNA that translates efficiently while limiting innate immune and stress-response barriers. This guide converts the NPC1 rescue study into a practical workflow for reporter assays, patient-derived fibroblasts, and functional protein-expression experiments.

• IR-1061 Near Infrared Fluorescent Dye Workflow

  2026-09-02

  IR-1061 is a hydrophobic NIR-II fluorophore for low-background deep-tissue, vascular, and optical imaging workflows. This guide translates its solvent constraints and aggregation-sensitive behavior into practical preparation, formulation, QC, and troubleshooting decisions.

7988 records 1/533 page Next 12345 下5页 Last page